NFKB1 and gastric cancer: In the present study, we identified that miR-1228* was down-regulated in more than 70% of gastric cancer samples when compared with their nontumor counterparts and provide experimental evidence that it may function as a tumor suppressor through negatively regulating EMT and inhibiting NF-κB activity.